HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Tatjana Traub-Weidinger Selected Research

indium 111-DOTA-lanreotide

12/2005Somatostatin receptor scintigraphy with 111In-DOTA-lanreotide and 111In-DOTA-Tyr3-octreotide in patients with stage IV melanoma: in-vitro and in-vivo results.
10/2005Value of 111In-DOTA-lanreotide and 111In-DOTA-DPhe1-Tyr3-octreotide in differentiated thyroid cancer: results of in vitro binding studies and in vivo comparison with 18F-FDG PET.
8/2003111In-DOTA- dPhe1-Tyr3-octreotide, 111In-DOTA-lanreotide and 67Ga citrate scintigraphy for visualisation of extranodal marginal zone B-cell lymphoma of the MALT type: a comparative study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Tatjana Traub-Weidinger Research Topics

Disease

7Neoplasms (Cancer)
05/2022 - 12/2015
7Glioma (Gliomas)
04/2022 - 01/2013
4Brain Neoplasms (Brain Tumor)
04/2022 - 01/2017
4Thyroid Neoplasms (Thyroid Cancer)
12/2015 - 10/2005
3Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder)
01/2017 - 12/2014
2Amyloidosis
07/2022 - 10/2020
2Melanoma (Melanoma, Malignant)
04/2021 - 12/2005
2Lymphoma (Lymphomas)
01/2021 - 01/2011
2Epilepsy (Aura)
01/2020 - 12/2016
2Marginal Zone B-Cell Lymphoma (MALT Lymphoma)
01/2011 - 08/2003
1Polyneuropathies (Polyneuropathy)
07/2022
1Thyroid Nodule (Nodule, Thyroid)
05/2022
1Primary Hyperparathyroidism
05/2022
1Ovarian Neoplasms (Ovarian Cancer)
03/2022
1Mood Disorders (Mood Disorder)
11/2021
1Neurocutaneous melanosis
04/2021
1Hallucinations (Hallucination)
01/2021
1Movement Disorders (Movement Disorder)
01/2021
1Parkinsonian Disorders (Parkinsonism)
01/2021
1Hypokinesia (Bradykinesia)
01/2021
1Neurodegenerative Diseases (Neurodegenerative Disease)
11/2020
1Amyloid Plaque
10/2020
1Neurofibrosarcoma (MPNST)
01/2018
1Neurofibromatosis 1 (Neurofibromatosis Type I)
01/2017
1Nerve Sheath Neoplasms (Nerve Sheath Neoplasm)
01/2017
1Neurofibroma
01/2017
1Goiter
11/2014
1Hypothyroidism
03/2012
1Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular)
01/2011
1Body Weight (Weight, Body)
01/2011
1Somatostatinoma
06/2005
1Vipoma (WDHA)
06/2005
1Glucagonoma
06/2005
1Insulinoma
06/2005
1Gastrinoma
06/2005
1Carcinoid Tumor (Carcinoid)
06/2005
1Hodgkin Disease (Hodgkin's Disease)
08/2003
1Non-Hodgkin Lymphoma (Lymphosarcoma)
08/2003

Drug/Important Bio-Agent (IBA)

5Amino AcidsFDA Link
04/2022 - 01/2018
4Somatostatin Receptors (Somatostatin Receptor)IBA
12/2015 - 08/2003
3AcidsIBA
07/2022 - 12/2005
3Glucose (Dextrose)FDA LinkGeneric
01/2020 - 12/2015
3Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link
01/2017 - 10/2005
31,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA
12/2015 - 10/2005
3indium 111-DOTA-lanreotideIBA
12/2005 - 08/2003
2Prealbumin (Transthyretin)IBA
07/2022 - 10/2020
2Biomarkers (Surrogate Marker)IBA
04/2022 - 01/2017
2AntigensIBA
03/2022 - 06/2021
2Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA
06/2021 - 01/2018
2Methionine (L-Methionine)FDA Link
06/2021 - 01/2018
2Deoxyglucose (2 Deoxy D glucose)IBA
01/2020 - 01/2018
2Norepinephrine Plasma Membrane Transport Proteins (Norepinephrine Transporter)IBA
03/2016 - 12/2014
2Octreotide (Sandostatin)FDA LinkGeneric
12/2015 - 12/2005
2lanreotide (Somatuline)FDA Link
12/2015 - 12/2005
1Technetium Tc 99m Sestamibi (Cardiolite)FDA LinkGeneric
05/2022
1Glutamine (L-Glutamine)FDA Link
04/2022
1Glycine (Aminoacetic Acid)FDA LinkGeneric
04/2022
1Monoamine Oxidase (MAO)IBA
11/2021
1Testosterone (Sustanon)FDA Link
11/2021
1ParaffinIBA
06/2021
1Biological ProductsIBA
04/2021
168Ga-pentixaforIBA
01/2021
13,4-methylenedioxyethamphetamine (MDEA)IBA
01/2021
1Dopamine Plasma Membrane Transport Proteins (Dopamine Transporter)IBA
01/2021
12- carbomethoxy- 8- (3- fluoropropyl)- 3- (4- iodophenyl)tropaneIBA
01/2021
1Retinaldehyde (Retinal)IBA
11/2020
1Oxygen (Dioxygen)IBA
11/2020
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
12/2018
168Ga-DOTANOCIBA
01/2017
1Serotonin Plasma Membrane Transport Proteins (Serotonin Transporter)IBA
01/2017
1IGF-I-IGFBP-3 complexFDA Link
03/2016
13' Untranslated Regions (3' UTR)IBA
03/2016
15' Untranslated Regions (5' UTR)IBA
03/2016
1LigandsIBA
12/2015
1morpholineIBA
12/2014
1protoporphyrin IXIBA
01/2013
1Thyroxine (Levothyroxine)FDA LinkGeneric
03/2012
1ibritumomab tiuxetan (Zevalin)FDA Link
01/2011
1Rituximab (Mabthera)FDA Link
01/2011
1RadiopharmaceuticalsIBA
03/2010
1Tyrosine (L-Tyrosine)FDA Link
12/2005
1Citric Acid (Citrate)FDA LinkGeneric
08/2003
1Gallium-67IBA
08/2003

Therapy/Procedure

4Therapeutics
07/2022 - 01/2011
1Parathyroidectomy
05/2022
1Thyroidectomy
11/2014
1Radioimmunotherapy
01/2011